Skip to content

Drug interactions

Inotuzumab + Oxaliplatin

Severity: Moderate

Inotuzumab and Oxaliplatin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Inotuzumab ozogamicin is associated with QT prolongation, and oxaliplatin has also been linked to QT changes. Combined use may increase the risk of ventricular arrhythmias, particularly with electrolyte abnormalities.

What this interaction means in plain words

Inotuzumab and Oxaliplatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive QT interval prolongation through pharmacodynamic effects.

What to do

Check ECG and electrolytes before and during treatment, and correct potassium and magnesium deficits. Avoid other QT-prolonging drugs where possible.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Inotuzumab and Oxaliplatin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Inotuzumab with Oxaliplatin?

MediHelp rates the interaction as moderate. Inotuzumab and Oxaliplatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Inotuzumab ozogamicin is associated with QT prolongation, and oxaliplatin has also been linked to QT changes. Combined use may increase the risk of ventricular arrhythmias, particularly with electrolyte abnormalities.

How serious is the interaction between Inotuzumab and Oxaliplatin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check ECG and electrolytes before and during treatment, and correct potassium and magnesium deficits. Avoid other QT-prolonging drugs where possible.

What other medicines interact with Oxaliplatin?

MediHelp also lists interactions of Oxaliplatin with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Oxaliplatin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in